U.S. FDA approval

Medtronic: U.S. FDA approval for the Endurant(TM) II/IIs stent graft system

New Indication Expands Treatment Options for AAA Patients with Hostile Neck Anatomy DUBLIN, 11-Oct-2017 — /EuropaWire/ — Medtronic plc (NYSE:…

7 years ago

Medtronic: U.S. FDA approval for HawkOne Directional Atherectomy System for patients with peripheral artery disease (PAD)

New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 27-Oct-2016 —…

8 years ago